COMMUNIQUÉS West-GlobeNewswire

Aeroflow Health Celebrates the Success of Nebraska’s Passage of Bill LB1215, Featuring Provisions to Include Access to Products & Services for Expecting and New Mothers
22/04/2024
The national durable medical equipment provider was active in achieving the necessary provisions in Bill L1215 to increase access to breast pumps and lactation consultations ASHEVILLE, N.C., April 22, 2024 (GLOBE [...]
VIVUS Announces it will Provide Telehealth to Patients through an Enhanced 'Engage' Program in Collaboration with UpScriptHealth
22/04/2024
Collaboration will deliver a seamless telehealth experience, providing patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing their healthcare journey CAMPBELL, Calif., April 22, 2024 ( [...]
APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023
22/04/2024
SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR ) (“ Mobile-Health ” or the “ Company ”), a pioneering Asia-Pacific (“APAC”) telehealth provider, today provided financial [...]
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings
22/04/2024
BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to [...]
Cidara Therapeutics Announces Reverse Stock Split
22/04/2024
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) [...]
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
22/04/2024
Interim readout of 22 patients shows unprecedented efficacy data compared to prior atopic dermatitis (AD) studies with biologics: 60.0% of dupilumab -experienced AD patients treated with 400mg eblasakimab weekly [...]
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
22/04/2024
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE [...]
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
22/04/2024
Raised gross proceeds of $59 million through the issuance and sale of 5,000,000 of its ordinary shares to Icelandic institutional and existing investors Becomes second company dual-listed on NASDAQ U.S. and NASDAQ [...]
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
22/04/2024
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters
22/04/2024
Selective CVN293 may have treatment potential in multiple neurodegenerative conditions BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central [...]
Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
22/04/2024
SOLANA BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Nova Leap Health Corp. to Discuss Record 2023 Results and Present at the Planet MicroCap Showcase
22/04/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, April 22, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
22/04/2024
GAITHERSBURG, Md., April 22, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss the financial results for the first [...]
Amarin Announces Results of Annual General Meeting of Shareholders
22/04/2024
- Shareholders Approve Share Repurchase Program of up to $50 Million - DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval [...]
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
22/04/2024
The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ET CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX [...]
DLH to Announce Fiscal 2024 Second Quarter Financial Results
22/04/2024
ATLANTA, April 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the [...]
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
22/04/2024
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certain business [...]
ORYZON Secures Another Important Patent for its Lead CNS Asset, Vafidemstat
22/04/2024
Has received “Intention to Grant” from the European Patent Office For the treatment of aggression and social withdrawal MADRID, Spain and CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN [...]
Celularity Inc. to Host Investor and Analyst Research & Development Day
22/04/2024
Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress FLORHAM PARK, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a [...]

Pages